
2026 Precision Targeted Drug Breakthroughs: Customized Treatment Brings New Hope for Rare Cancers
This blog, based on 5 global multicenter clinical studies in 2026, interprets the new breakthroughs of precision targeted drugs for rare cancers from the perspective of a pharmacology professor with 20 years of experience. It focuses on customized "one patient, one drug" treatment mode, explains the mechanism of new drugs such as larotrectinib and selpercatinib in plain language, quotes accurate clinical data, points out common medication pitfalls, and conveys rational hope that rare cancers are no longer incurable. It adheres to a rigorous and pragmatic style, avoids exaggeration, and emphasizes medication safety.
As an integrative medicine specialist with 20 years of clinical experience, I am dedicated to exploring the synergy between Traditional C…
